Abstract. A linear support vector machine (SVM) is used to extract 6 features from a total of 31 features in a dataset of 253 breast cancer patients. Five features are nuclear features obtained during a non-invasive diagnostic procedure while one feature, tumor size, is obtained during surgery. The linear SVM selected the 6 features in the process of classifying the patients into node-positive (patients with some metastasized lymph nodes) and nodenegative (patients with no metastasized lymph nodes). Node-positive patients are typically those who undergo chemotherapy. The 6 features were then used in a Gaussian kernel nonlinear SVM to classify the patients into three prognostic groups: good (node-negative), intermediate (1 to 4 metastasized nodes) and poor (more than 4 metastasized nodes). Very well separated Kaplan-Meier survival curves were constructed for the three groups with pairwise p-value of less than 0.009 based on the logrank statistic. Patients in the good prognostic group had the highest survival, while patients in the poor prognostic group had the lowest. The majority (72.8%) of the good group did not receive chemotherapy, while the majority (87.5%) of the poor group received chemotherapy. Just over half (56.7%) of the intermediate group received chemotherapy. New patients can be assigned to one of these three prognostic groups with its associated survival curve, based only on 6 features obtained before and during surgery, but without the potentially risky procedure of removing lymph nodes to determine how many of them have metastasized.
Introduction
Support vector machines [Vap95, CM98] as well as linear programming approaches [Man65, Man68, BM92] have been extensively used in machine learning and data mining applications [Man97, BMS98, BM98a, BM98b, BFM99] as well as in medical applications [MSW95, WSM93, WSHM95b, WSHM95a, WSM97] . In this work we attempt to classify breast cancer patients using a criterion that is closely related to the decision whether a patient is prescribed to have chemotherapy treatment or not. This criterion is the presence of metastasized lymph nodes under the patient's armpits (node-positive) or their absence (node-negative). Lymph nodes are removed during surgery in conjunction with the removal of the malignant tumor from the breast. This potentially risky procedure which can cause arm swelling and increased susceptibility to infection can possibly be eliminated by using the classification procedures proposed here. By using a linear support vector machine we first select 6 out of 31 available features to classify patients into node-positive and node-negative patients. We then use these six features in a nonlinear support vector machine to classify 253 breast cancer patients into three prognosis groups: a good prognosis group (GPG) which is node-negative, an intermediate prognosis group (IPG) which has 1-4 metastasized lymph nodes, and a poor prognosis group (PPG) which has more than 4 metastasized lymph nodes. It turns out that these three groups have well separated survival curves [KM58, Kle96] with very small inter-curve p-values (Figure 3 ). In addition, 72.8% of the patients in GPG did not take chemotherapy, while 87.5% of the patients in PPG took chemotherapy. Only 56.7% of patients in IPG took chemotherapy. Thus our classification procedure can be utilized to assign new patients to one of three prognostic groups with an associated survival curve and a possible indication of the utilization of chemotherapy or not.
The paper is organized as follows. Section 2 gives a basic description of the essentials of support vector machines. Section 3 applies the ideas described in Section 2 to the problem of classifying patients using lymph node status as a classification criterion. Section 4 gives some brief conclusions.
A word about our notation now. All vectors will be column vectors unless transposed to a row vector by a prime superscript ′ . The scalar (inner) product of two vectors x and y in the n-dimensional real space R n will be denoted by x ′ y. For a general norm · on R n , the dual norm · ′ on R n is defined as
, the p-norm · p and q-norm · q are dual norms. Thus the 1-norm · 1 and ∞-norm · ∞ are dual norms while the 2-norm is self-dual. For an ℓ × n matrix A, A i will denote the ith row of A. The identity matrix in a real space of arbitrary dimension will be denoted by I, while a column vector of ones of arbitrary dimension will be denoted by e. We shall employ the MATLAB "dot" notation [MAT92] to signify application of a function to all components of a matrix or a vector. For example if A ∈ R ℓ×n , then A
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• ∈ R ℓ×n will denote the matrix obtained by squaring each element of A.
Support Vector Machines
We begin with the simple linear support vector machine formulation as follows:
Here, ν is a positive weight, · is an arbitrary norm and the m × n matrix A represents m given points in R n which belong to class 1 or -1 depending on whether the corresponding elements of the given m × m diagonal matrix D are 1 or -1 respectively. The plane in R n , with normal w and distance from the origin from the origin, generated by a solution (w, γ) of the above mathematical program:
strictly separates the set A+ :
and only if the slack variable y ∈ R m is zero as shown in Figure 1 . The margin or distance (measured by a norm · ′ that is dual to the norm · of (2.1)) between the bounding planes x ′ w = γ ± 1 is given by 2 w [Man99] . These two planes are parallel to the plane x ′ w = γ and bound the sets A+ and A−. For ν ≥ν for someν > 0 [MM79, Theorem 4], the margin is maximized by a solution of (2.1) that suppresses the slack variable y first. When the sets A+ and A− are not strictly linearly separable, some components y i of the slack variable y will be positive. The points A i in either A+ or A− corresponding to positive y i , as well as those corresponding to zero y i but with positive Lagrange multipliers, are termed support vectors. Points A i with positive y i lie on the wrong sides of the bounding planes x ′ w = γ ± 1, while points with positive multipliers and zero slacks y i lie on the bounding planes.
We shall employ the 1-norm in the SVM formulation which leads to the following linear programming formulation which has been shown [BM98a] to have one of the best feature selection properties among all norms including the conventional 2-norm-squared formulation [Vap95, CM98] :
This linear programming formulation will be our SVM1 formulation that will be used for feature selection in the next section of the paper.
In order to obtain a nonlinear support vector machine with a nonlinear separating surface, we make use of the following transformation based on the dual formulation for the 2-norm-squared support vector machine [Man00] : 
with the following nonlinear separating surface instead of a plane:
Typical kernel functions are the following:
• * denotes the step function: R −→ {0, 1} component-wise. Using the 1-norm in (2.6) leads to a linear programming formulation of the nonlinear GSVM that we will be using in this work:
This nonlinear GSVM, which is capable of discriminating between elements of fairly complex sets, such as the black and white squares of a checkerboard [MM99, LM99] , will be used in the next section. We note that even though the nonlinear GSVM (2.8) is capable of achieving fairly complex separation, it is not suited for feature selection, because the kernel K(A, A ′ ) creates interactions between all the features through the variable u which is not present in SVM1 (2.3). That is the reason we used the linear SVM1 for feature selection and the nonlinear GSVM for the final separation.
Breast Cancer Prognosis and Chemotherapy
In this section of the paper we shall use the support vector machines described in the previous section to discriminate between 253 breast cancer patients. The dataset for these patients is publicly available [WLM99] . Our criterion for discrimination will be the absence or presence of metastasized lymph nodes (1 to 30 nodes) removed from the patient's armpit during surgery. Lymph node metastasis is a strong indicator for chemotherapy. The total number of features used to constitute the n-dimensional space in which the separation is accomplished is made up of the mean, standard deviation, and maximum (worst) value of ten cytological nuclear measurements of size, shape and texture taken from the patients breast by a non-surgical fine needle aspirate procedure [Str94, MSW95] together with the tumor size excised from the patient's breast during surgery. Taken together these constitute the 31-dimensional feature space over which classification according to lymph node metastasis will be achieved.
Before proceeding with our classification process we exhibit Kaplan-Meier survival curves [Kle96] for 140 of the 253 patients who had chemotherapy and for the remaining 113 patients that did not have chemotherapy in Figure 2 . The solid curve gives the percent of surviving patients as a function of time for the group that received chemotherapy, while the dashed curve gives the corresponding survival curve for the group that did not receive chemotherapy. One possible interpretation of this curve is that the patients not receiving chemotherapy and who have a better survival curve than those who are receiving chemotherapy, are not being compromised by not receiving chemotherapy. Another interpretation is that most patients who had chemotherapy were preselected for having lymph node metastasis and hence had inherently worse cancers. The p-value based on the logrank statistic [Kle96] relating these two curves is 0.0018. Hence these two curves are statistically distinct. (The logrank statistic is a comparative measure of the survival times of two groups which calculates a weighted sum of the difference, at each time interval, of the mortality ratio between the two groups: m1 m2 , and the population ratio between the two groups: n1 n2 . Here, m i is the number of deaths in group i and n i is the number of people in group i. The logrank statistic for two groups has a Chi-squared distribution with degree of freedom one [Kle96] . Larger logrank statistic indicates significantly different survival curves. That corresponds to a small p-value. The p-value is the probability that the two survival curves are statistically the same.)
Our next result is the classification of the 253 patients into three prognostic groups as follows:
1. Good Prognosis "Node-negative patients": Patients with no metastasized lymph nodes. 2. Intermediate Prognosis "Node-positive patients" with 1 to 4 metastasized lymph nodes. 3. Poor Prognosis "Node-positive patients" with more than 4 metastasized lymph nodes.
To achieve this classification we first used SVM1 (2.3) to separate node-negative patients from node-positive patients. By using a sufficiently small value of ν in (2.3), ν = 0.02, the SVM1 formulation (2.3) suppressed 25 of the 31 features and selected a total of 6 features as follows:
1. Mean Area 2. Standard Deviation of Area 3. Worst Area 4. Worst Texture 5. Worst Perimeter 6. Tumor Size (from surgery)
Note that the first five are cytological features obtained from the fine needle aspirate taken during diagnosis. We next used the nonlinear support vector machine GSVM (2.8) with a Gaussian kernel with ν = 0.096 to achieve our three-class separation as follows:
1. GPG: Good prognosis group (0 lymph node metastasis) was separated from all the rest for which: 2. IPG: Intermediate prognosis group (1-4 lymph node metastasis) was separated from: PPG: Poor prognosis group (lymph node metastasis > 4).
Note that the separation in Step 2 above included some node-negative patients in IPG because the separation of Step 1 is not perfect and GPG does not include all node-negative patients. Tenfold cross validation correctness [Sto74] for the above separation was 72.8%. Based on the above separation we constructed three Kaplan-Meier survival curves for each of the three prognostic groups: GPG, IPG and PPG as shown in Figure 3 . Note that the three curves are very well separated and the p-values between the three groups are as follows:
1. GPG-IPG p-value=0.0090 2. GPG-PPG p-value=9.5769e-06 3. IPG-PPG p-value=0.0037
These p-values are substantially smaller than the conventional 0.05 cutoff used to reject the null-hypothesis (survival curves are the same). Hence these curves are indeed statistically significantly different from each other.
It is worth noting within each of the three prognosis groups how many patients received and did not receive chemotherapy: Within each prognosis group, there was no statistically significant difference based on p-values, between the survival curves of patients who took and did not take chemotherapy.
In contrast to the three survival curves based on the GPG, IPG and PPG groups, we constructed three other survival curves based solely on the number of metastasized lymph nodes, the conventional indicator for chemotherapy prescription, as shown in Figure 4 . It is interesting to observe the large p-values between the node-negative survival curve and the 1-4 lymph node survival curve (p-value=0.1137), and between the latter curve and the 5-30 lymph node survival curve (p-value=0.028). This indicates that our criteria for GPG-IPG-PPG classification based on the six features selected by SVM1, which do not include lymph node status, yield statistically more distinct survival curves than those based on lymph node status by itself.
Conclusions
Based on the results presented in this work, the following conclusions can be made:
• Support vector machines can be used to:
-Select features that are important for prognosis.
-Classify breast cancer patients into three groups with well separated survival curves.
• Most (72.8%) patients in good group received no chemotherapy.
• Most (87.5%) patients in poor group received chemotherapy.
• Just over half the patients (56.7%) in intermediate group received chemotherapy.
• Survival curves and possible chemotherapy decision for new patients can be determined by assigning them to one of the three groups based on five nuclear features and tumor size without the need for lymph node status.
